INTRAVITREAL INFLIXIMAB IN PATIENTS WITH MACULAR DEGENERATION WHO ARE NONRESPONDERS TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

More Questions Than Answers: A Call for a Moratorium on the Use of Intravitreal Infliximab Outside of a Well-Designed Trial

(2010) Jose S. Pulido et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

ADVERSE EVENTS AFTER INTRAVITREAL INFLIXIMAB (REMICADE)

(2010) MONICA GIGANTI et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

When Is Off-Label Drug Use in the Patient's Best Interest?

(2009) Philip J. Rosenfeld et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Intravitreal Administration of the Anti-Tumor Necrosis Factor Agent Infliximab for Neovascular Age-related Macular Degeneration

(2009) Panagiotis G. Theodossiadis et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a Prospective Study

(2009) Ziad F. Bashshur et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone

(2009) P P Yip et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab

(2008) Hiroki Mitoma et al.   ARTHRITIS AND RHEUMATISM

Intravitreal administration of the anti-TNF monoclonal antibody Infliximab in the rabbit

(2008) Panagiotis G. Theodossiadis et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Adalimumab Therapy for Refractory Uveitis: A Pilot Study

(2008) Manuel Diaz-Llopis et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS